THE SHARP BUILDING, DUBLIN 2, L2
Reports Second Quarter 2025 Financial Results From Continuing Operations
Announces Proposed Divestiture of Dermacosmetics Business for up to €327 Million
Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
Announces Global Operations and Supply Chain Leadership Transition
Reports First Quarter 2025 Financial Results From Continuing Operations
Shareholder votes
Annual Report to Security Holders
Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Certificate
Registration of Securities
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Free Writing Prospectus